|
|
|
Insider
Information: |
Czirr James C |
Relationship: |
10% Owner |
City: |
Sandpoint |
State: |
ID |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
6,168,940 |
|
Indirect Shares
|
5,922,207 |
|
|
Direct
Value |
$13,571,668 |
|
|
Indirect Value
|
$13,028,855 |
|
|
Total
Shares |
12,091,147 |
|
|
Total
Value |
$26,600,523 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
3
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
3
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
Percentage
Gain/Loss : |
0.0%
|
-98.3%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
![](../../../Gifs/iconPlus.jpg) |
Galectin Therapeutics Inc |
GALT |
10% Owner |
2022-07-22 |
6,168,940 |
2024-04-23 |
5,922,207 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GALT |
Galectin Therapeutics Inc |
Executive Chairman |
|
2014-01-10 |
4 |
S |
$16.00 |
$672,118 |
I/I |
(42,000) |
9,415,422 |
0 |
- |
|
GALT |
Galectin Therapeutics Inc |
Executive Chairman |
|
2014-01-13 |
4 |
S |
$14.00 |
$812,203 |
I/I |
(58,000) |
9,357,422 |
0 |
- |
|
GALT |
Galectin Therapeutics Inc |
Executive Chairman |
|
2013-10-08 |
4 |
S |
$12.36 |
$148,270 |
I/I |
(12,000) |
8,957,422 |
0 |
- |
|
GALT |
Galectin Therapeutics Inc |
Executive Chairman |
|
2013-10-07 |
4 |
S |
$11.79 |
$1,179,160 |
I/I |
(100,000) |
8,969,422 |
0 |
- |
|
GALT |
Galectin Therapeutics Inc |
Director |
|
2018-06-18 |
4 |
AS |
$9.06 |
$543,600 |
I/I |
(60,000) |
2,649,786 |
0 |
- |
|
GALT |
Galectin Therapeutics Inc |
Director |
|
2018-06-15 |
4 |
AS |
$8.47 |
$131,073 |
I/I |
(15,475) |
2,709,786 |
0 |
- |
|
GALT |
Galectin Therapeutics Inc |
Director |
|
2018-06-14 |
4 |
AS |
$7.99 |
$632,133 |
I/I |
(76,385) |
2,725,261 |
0 |
- |
|
GALT |
Galectin Therapeutics Inc |
Executive Chairman |
|
2013-11-15 |
4 |
B |
$6.90 |
$6,897 |
D/D |
1,000 |
844,450 |
2.81 |
- |
|
GALT |
Galectin Therapeutics Inc |
Director |
|
2018-06-13 |
4 |
AS |
$6.59 |
$1,493,276 |
I/I |
(208,140) |
2,801,646 |
0 |
- |
|
GALT |
Galectin Therapeutics Inc |
Director |
|
2017-03-31 |
4 |
A |
$6.00 |
$6,000 |
D/D |
1,000 |
888,630 |
0 |
- |
|
GALT |
Galectin Therapeutics Inc |
Exec. V.P. of Business Dev. |
|
2003-10-06 |
4 |
S |
$5.75 |
$100,050 |
D/D |
(17,400) |
4,837,368 |
|
- |
|
GALT |
Galectin Therapeutics Inc |
Director |
|
2018-06-08 |
4 |
AS |
$5.64 |
$646,800 |
I/I |
(110,000) |
3,009,786 |
0 |
- |
|
GALT |
Galectin Therapeutics Inc |
Director |
|
2018-01-25 |
4 |
S |
$5.45 |
$1,118,035 |
I/I |
(205,144) |
3,160,284 |
0 |
- |
|
GALT |
Galectin Therapeutics Inc |
Director |
|
2018-01-26 |
4 |
S |
$5.35 |
$210,255 |
I/I |
(39,300) |
3,120,984 |
0 |
- |
|
GALT |
Galectin Therapeutics Inc |
Director |
|
2018-06-04 |
4 |
S |
$5.13 |
$41,517 |
I/I |
(8,093) |
3,119,786 |
0 |
- |
|
GALT |
Galectin Therapeutics Inc |
Director |
|
2018-06-01 |
4 |
S |
$5.12 |
$214,564 |
I/I |
(41,907) |
3,161,693 |
0 |
- |
|
GALT |
Galectin Therapeutics Inc |
Director |
|
2021-04-28 |
4/A |
AS |
$5.02 |
$50,200 |
D/D |
(10,000) |
6,288,940 |
0 |
- |
|
GALT |
Galectin Therapeutics Inc |
Director |
|
2021-04-26 |
4 |
AS |
$4.47 |
$33,525 |
D/D |
(7,500) |
6,298,940 |
0 |
% |
|
GALT |
Galectin Therapeutics Inc |
Director |
|
2021-04-23 |
4 |
AS |
$3.95 |
$19,750 |
D/D |
(5,000) |
6,306,440 |
0 |
% |
|
GALT |
Galectin Therapeutics Inc |
10% Owner |
|
2006-04-03 |
4 |
AS |
$3.93 |
$78,600 |
D/D |
(20,000) |
4,292,268 |
|
- |
|
GALT |
Galectin Therapeutics Inc |
Director |
|
2021-06-01 |
4 |
AS |
$3.91 |
$39,100 |
D/D |
(10,000) |
6,268,940 |
0 |
% |
|
GALT |
Galectin Therapeutics Inc |
Director |
|
2021-09-01 |
4 |
AS |
$3.91 |
$39,100 |
D/D |
(10,000) |
6,238,940 |
0 |
% |
|
GALT |
Galectin Therapeutics Inc |
Director |
|
2021-05-03 |
4/A |
AS |
$3.84 |
$38,400 |
D/D |
(10,000) |
6,278,940 |
0 |
- |
|
GALT |
Galectin Therapeutics Inc |
Director |
|
2021-05-03 |
4 |
AS |
$3.84 |
$38,400 |
D/D |
(10,000) |
6,288,940 |
0 |
% |
|
GALT |
Galectin Therapeutics Inc |
10% Owner |
|
2003-12-12 |
4 |
S |
$3.79 |
$284,250 |
D/D |
(75,000) |
4,779,768 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|